Sucampo Pharmaceuticals- Product Pipeline Review

Bharatbook.com announces a new report on "Sucampo Pharmaceuticals- Product Pipeline Review " which provides data on the Sucampo Pharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

ListFree.org (Press Release) - Monday, October 14th, 2013

Oct 14, 2013 : Bharat Book Bureau presents the new report, on ‘Sucampo Pharmaceuticals- Product Pipeline Review ‘ provides data on the N30 Pharmaceuticals’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Sucampo Pharmaceuticals, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Sucampo Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Sucampo Pharmaceuticals, Inc. – Brief Sucampo Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Sucampo Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Sucampo Pharmaceuticals, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Sucampo Pharmaceuticals, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Sucampo Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Sucampo Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Sucampo Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Sucampo Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Sucampo Pharmaceuticals, Inc. and identify potential opportunities in those areas.

Table of contents :
Table of Contents 2
List of Tables 4
List of Figures 4
Sucampo Pharmaceuticals, Inc. Snapshot 5
Sucampo Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Sucampo Pharmaceuticals, Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Sucampo Pharmaceuticals, Inc. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Sucampo Pharmaceuticals, Inc. – Pipeline Products Glance 10
Sucampo Pharmaceuticals, Inc. – Late Stage Pipeline 10
Phase III Products/Combination Treatment Modalities 10
Sucampo Pharmaceuticals, Inc. Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Sucampo Pharmaceuticals, Inc. – Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Sucampo Pharmaceuticals, Inc. – Drug Profiles 14
cobiprostone 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
lubiprostone 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
SPI-017 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
SPI-3608 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
unoprostone isopropyl 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Sucampo Pharmaceuticals, Inc. – Pipeline Analysis 19
Sucampo Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class 19
Sucampo Pharmaceuticals, Inc. – Pipeline Products By Target 21
Sucampo Pharmaceuticals, Inc. – Pipeline Products by Route of Administration 22
Sucampo Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action 23
Sucampo Pharmaceuticals, Inc. – Recent Pipeline Updates 24
Sucampo Pharmaceuticals, Inc. – Dormant Projects 30
Sucampo Pharmaceuticals, Inc. – Locations And Subsidiaries 31
Head Office 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 33
Disclaimer 33

List of Tables
Sucampo Pharmaceuticals, Inc., Key Information 5
Sucampo Pharmaceuticals, Inc., Key Facts 5
Sucampo Pharmaceuticals, Inc. – Pipeline by Indication, 2013 7
Sucampo Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2013 8
Sucampo Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2013 9
Sucampo Pharmaceuticals, Inc. – Phase III, 2013 10
Sucampo Pharmaceuticals, Inc. – Phase II, 2013 11
Sucampo Pharmaceuticals, Inc. – Phase I, 2013 12
Sucampo Pharmaceuticals, Inc. – Preclinical, 2013 13
Sucampo Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2013 20
Sucampo Pharmaceuticals, Inc. – Pipeline By Target, 2013 21
Sucampo Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2013 22
Sucampo Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action, 2013 23
Sucampo Pharmaceuticals, Inc. – Recent Pipeline Updates, 2013 24
Sucampo Pharmaceuticals, Inc. – Dormant Developmental Projects,2013 30

List of Figures
Sucampo Pharmaceuticals, Inc. – Pipeline by Indication, 2013 7
Sucampo Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2013 8
Sucampo Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2013 9
Sucampo Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2013 19
Sucampo Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2013 22
Sucampo Pharmaceuticals, Inc. – Pipeline Products By Mechanism of Action, 2013 23
For more information kindly visit : http://www.bharatbook.com/healthcare-market-research-reports/sucampo-pharmaceuticals-inc-product-pipeline-review-2013.html
Related link : http://www.bharatbook.com/market-research-report/pharmaceuticals-and-healthcare.html

About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.
Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Call UK +44 7405 208461
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: https://twitter.com/researchbook
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : http://blog.bharatbook.com/

ListFree.org: Embedded data.

Bookmark and Share Subscribe

 

Contact us at :
Issued By:sandhya nair
Email:sandhya@bharatbook.com
Street:Office No.810, Real Tech Park, 8th Floor, Plot No. 39/2, Sector-30A,Vashi,
Town:Navi Mumbai
Country:india
Phone:+91 22 27810772
Fax:+91 22 27812290
WebSite:http://www.bharatbook.com/healthcare-market-research-reports/sucampo-pharmaceuticals-inc-product-pipeline-review-2013.html
Categories:Business
Tags:,

You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.